Please find all related articles below.
1st April, Brussels - The European Parliament’s committee on Environment, Public Health and Food Safety supported yesterday a resolution calling for a new EU strategy to tackle health harm from alcohol to be put into action for 2016-2022. The Resolution also emphasizes the importance of better labeling of alcoholic drinks including ingredients and nutritional information.
A coalition of public health organisations (1) working on alcohol policy welcomes the committee’s position (...)
National government representatives have given the green light to a new EU Strategy on Alcohol: The Committee on National Alcohol Policy and Action (CNAPA) of national experts has adopted a scoping paper on the EU approach to harmful use of alcohol and alcohol related harm. The document contains the main elements that CNAPA would like to see in a new EU Alcohol Strategy.
National governments are largely responsible for their own alcohol policies, however these were previously complemented (...)
MEP Cristian Buşoi (EPP, RO) will launch the ’MEP Friends of the Liver Group’. The event is organised in collaboration with the European Association for the Study of the Liver (EASL).
27 May 2015, 13.00 – 15.00 | Venue: The European Parliament (Brussels), room tbc.
REGISTER HERE (Deadline: Wednesday, 20 May 2015)
AGENDA (coming shortly)
MEP Friends of the Liver Interest Group:
Dr Christian Busoi, the European Association for the Study of the (...)
Free trade agreements (FTAs) have the declared aim of seeking to increase global trade and promote economic growth. Historically, economic growth has led to improved population health. Yet this link is now weakening, and attention is being focussed on assessing the effect of FTAs on health and the ability of government to mitigate against negative impact. Within this context, this study presents an assessment of the health impact of the proposed FTA between the United States and the (...)
On 10 December 2014, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’. The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other diseases, such as (...)
On 7 January, a meeting on ‘Regulation on Endocrine Disrupting Chemicals: an opportunity to stop cancer before it starts’ was held in the European Parliament, where MEPs, civil society organisations, and academics called for better regulation on Endocrine Disrupting Chemicals (EDC).
MEPs began the session, represented by Alojz Peterle (EPP, Slovenia), Pavel Poc (S&D, Czech Rep.) and Christel Schaldemose (S&D, Denmark). Mr Peterle pointed out that cancer is no longer (...)
While experts highlight the health effects and economic costs of air pollution, the European Commission is planning to amend the air quality proposal which is likely to have significant benefits for health right across Europe. In considering modifications to the EU clean air package, the European Commission has an opportunity to promote prevention and to consider people’s health.
Parliament Hearing to present scientific evidence on EU air quality policy
At the public hearing (...)
Brussels, 10 December 2014 – Today, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) (1) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’ (2). The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other (...)
In Brussels on 8th/9th/10th December 2014, EPHA will launch the first part of its 7th Professional Development Programme (PDP). The Autumn 2014 programme aims to train those new to the ‘EU bubble’ to get an introduction to key issues around public health advocacy in the EU.
EPHA PDP provides a chance for young professionals working primarily in health-related organisations or civil society organisations to gain a better understanding of:
How to campaign successfully through (...)
Brussels, 19 November 2014 - Chronic Obstructive Pulmonary Disease (COPD) (1) affects up to 10% of European adults and is the fourth cause of death worldwide and is expected to be in third place by 2030 (2). As yet, few EU leaders or policy-makers are aware of this fact. Until this changes, little political action will be given to tackle one of the most acute public health issues in Europe.
“As a first step to effectively address this public health threat, we should get much better (...)